CIVO
Showing 1 - 5 of 5
Solid Tumor Trial in United States (drug, combination product, biological)
Recruiting
- Solid Tumor
- Pembrolizumab
- +2 more
-
Sacramento, California
- +6 more
Jan 3, 2023
Soft Tissue Sarcoma Adult Trial in Lake Success, Portland, Seattle (Multiple drug microinjection, CIVO device)
Completed
- Soft Tissue Sarcoma Adult
- Multiple drug microinjection
- CIVO device
-
Lake Success, New York
- +2 more
Sep 22, 2021
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Ischemic Stroke Trial in Worldwide (Stent-retriever thrombectomy with revascularization device of the Solitaire™ type,
Active, not recruiting
- Ischemic Stroke
- Stent-retriever thrombectomy with revascularization device of the Solitaire™ type
- Intravenous thrombolysis with recombinant tissue-type plasminogen activator (IV t-PA)
-
Linz, Oberösterreich, Austria
- +47 more
May 21, 2021
Lymphoma Trial in Seattle (Multiple drug microinjection: rituximab, vincristine, doxorubicin, bendamustine, prednisolone or a
Completed
- Lymphoma
- Multiple drug microinjection: rituximab, vincristine, doxorubicin, bendamustine, prednisolone or a combination of them
-
Seattle, WashingtonSeattle Cancer Care Alliance
Feb 24, 2017